RSS
(PLX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 23, 2013
(Stock Blog Hub,
3/4/11)
Protalix BioTherapeutics, Inc. (PLX) was dealt a huge blow recently with the US Food and Drug Administration (FDA) issuing a complete response letter (CRL) for the...(read more)
(Benzinga,
9/14/10)
Shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) are popping higher today on word that its cell therapy data shows that its treatments are “Safe” and that its PLX cells may be effective therapy for neuropathic pain....(read more)
On 10/15/09, Protalix BioTherapeutics (AMEX:
PLX
) announced positive top-line results of a pivotal Phase 3 study of its lead drug candidate, UPLYSO (Taliglucerase Alfa) in treatment naïve...(read more)
Protalix BioTherapeutics (PLX) Company Overview
There is no analysis for PLX yet. But you can go to Wikinvest to help create one!
|
|
|
|
|
|
Copyright Notice |
Privacy Policy |
Information |
Subscriber Services |
Site Map |
RSS 
MNG Corporate Site Map | Newspaper Media Kit
MNG Corporate Site Map | Newspaper Media Kit
| For more local Southern California News: | Copyright ©2007 |
| Los Angeles Newspaper group |